Bevacizumab: A Review of its Use in Advanced Colorectal Cancer, Breast Cancer, and NSCLC

Author： Lyseng-Williamson Katherine A.   Robinson Dean M.  

Publisher： Adis International

ISSN： 1175-6357

Source： American Journal of Cancer, Vol.5, Iss.1, 2006-01, pp. : 43-60

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Letrozole: An Updated Review of its Use in Postmenopausal Women with Advanced Breast Cancer

By Keating G.M.   Jarvis B.  

American Journal of Cancer, Vol. 1, Iss. 5, 2002-01 ,pp. : 351-371

Adis International

Access to resources Recommend Favorite

Bevacizumab: In the Treatment of Colorectal Cancer

By Croom Katherine F.   Foster Rachel H.  

American Journal of Cancer, Vol. 3, Iss. 3, 2004-01 ,pp. : 187-194

Adis International

Access to resources Recommend Favorite

Bevacizumab in Advanced NSCLC: Chemotherapy Partners and Duration of Use

By Gentzler Ryan   Yentz Sarah   Patel Jyoti  

Current Treatment Options in Oncology, Vol. 14, Iss. 4, 2013-12 ,pp. : 595-609

Springer Publishing Company

Access to resources Recommend Favorite

Reasons for avoidance of bevacizumab with first-line FOLFOX for advanced colorectal cancer

By Hori Natsuko  

International Journal of Clinical Oncology, Vol. 18, Iss. 3, 2013-06 ,pp. : 435-438

Springer Publishing Company

Access to resources Recommend Favorite

Capecitabine and bevacizumab in heavily pre-treated patients with advanced colorectal cancer

By Larsen Finn Ole   Boisen Mogens Karsbøl   Fromm Annelene L.   Jensen Benny Vittrup  

Acta Oncologica, Vol. 51, Iss. 2, 2012-02 ,pp. : 231-233

Informa Healthcare

Access to resources Recommend Favorite